SLCO1A2 and chronic myelogenous leukemia, BCR-ABL1 positive: IM clearance in patients with CML was influenced by the SLCO1A2 −1105g>a/−1032g>a genotype (p = 0.075) and the SLCO1A2 -361gg genotype